At Ketavita Wellness Clinic, we offer specialized ketamine therapy for post-traumatic stress disorder that hasn’t responded adequately to traditional treatments. When conventional medications and trauma-focused psychotherapy haven’t provided sufficient relief from intrusive memories, avoidance behaviors, and hyperarousal symptoms, our IV and IM ketamine treatments offer a different approach through glutamate modulation that works rapidly to reduce PTSD symptoms.
Located in Wyckoff, New Jersey, our clinic provides evidence-based care from experienced medical professionals who understand the debilitating nature of trauma-related symptoms. We create personalized treatment plans designed to help you achieve meaningful symptom reduction, improving your quality of life and ability to engage in daily activities.
Every treatment journey begins with a comprehensive evaluation where we review your trauma history, current PTSD symptoms and their severity, previous treatments you’ve tried including medications and therapy approaches, how PTSD affects your daily functioning, and any co-occurring conditions like depression or anxiety. We work closely with you throughout treatment, monitoring your response and adjusting protocols to optimize outcomes.
Post-traumatic stress disorder is a psychiatric condition that develops following exposure to traumatic events involving actual or threatened death, serious injury, or sexual violence. PTSD affects approximately 7-8% of the US population at some point in their lives, with higher rates among military veterans, first responders, and survivors of severe trauma.
PTSD is characterized by four primary symptom clusters. Intrusive symptoms include unwanted, distressing memories of the traumatic event, nightmares, flashbacks where you feel as though the trauma is recurring, and intense psychological distress or physical reactions when exposed to trauma reminders. These intrusive experiences can occur suddenly and unexpectedly, significantly disrupting daily life.
Avoidance symptoms involve persistent efforts to avoid thoughts, feelings, or conversations about the trauma, as well as avoiding people, places, or activities that trigger memories of the traumatic event. While avoidance provides temporary relief from distress, it maintains PTSD symptoms by preventing natural processing of the traumatic experience and limiting your ability to engage in normal activities.
Negative alterations in cognition and mood include inability to remember important aspects of the trauma, persistent negative beliefs about yourself or the world, distorted blame of self or others for the trauma, persistent negative emotional states like fear or anger, diminished interest in activities, feelings of detachment from others, and inability to experience positive emotions. These changes affect relationships, work performance, and overall life satisfaction.
Alterations in arousal and reactivity manifest as irritability or aggressive behavior, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbances. These symptoms reflect a heightened state of threat detection that persists long after the danger has passed, making it difficult to relax or feel safe even in secure environments.
Treatment-resistant PTSD occurs when you haven’t achieved adequate symptom control despite receiving evidence-based first-line treatments. This typically means you’ve completed at least one adequate trial of an SSRI or SNRI medication at maximum tolerated dose for sufficient duration (typically 8-12 weeks), engaged in trauma-focused psychotherapy such as prolonged exposure therapy, cognitive processing therapy, or EMDR with a qualified therapist, or tried combination treatment of medication plus trauma-focused therapy without satisfactory improvement.
Research indicates that approximately 30-40% of PTSD patients don’t achieve adequate symptom remission with first-line treatments. If you’ve tried multiple medications without success, completed trauma-focused therapy but continue to have significant symptoms, experienced intolerable side effects from medications that prevented adequate trials, or remain significantly impaired in your daily functioning despite treatment, you likely have treatment-resistant PTSD.
Treatment resistance in PTSD doesn’t mean your condition is untreatable—it means your symptoms may require interventions targeting different neurobiological mechanisms. While standard PTSD medications primarily work through serotonin and norepinephrine systems, emerging research suggests glutamate neurotransmission plays an important role in fear memory consolidation and trauma-related symptoms. Ketamine acts as an NMDA receptor antagonist affecting glutamate activity, offering a fundamentally different therapeutic approach.
Living with treatment-resistant PTSD is exhausting and isolating. Persistent intrusive memories, constant hypervigilance, emotional numbness, and avoidance behaviors restrict your life and affect relationships, work performance, and overall wellbeing. The chronic nature of these symptoms can lead to hopelessness about recovery. Specialized treatments like ketamine therapy provide new hope for meaningful symptom reduction when conventional approaches haven’t worked.
Ketavita Wellness Clinic specializes in ketamine therapy for treatment-resistant post-traumatic stress disorder:
IV Ketamine Therapy delivers ketamine through intravenous infusion over approximately 40 minutes. This method allows precise dosing and continuous monitoring throughout treatment. Research indicates ketamine can provide rapid reduction in PTSD symptoms, with improvements often emerging within 24 hours rather than the 8-12 weeks typically required for conventional medications.
IM Ketamine Therapy provides ketamine through intramuscular injection, offering faster administration while delivering similar therapeutic benefits. This option eliminates IV placement and may be appropriate for certain patients based on individual factors and preferences.
Both IV and IM ketamine work through NMDA receptor antagonism, modulating glutamate neurotransmission in brain regions involved in fear memory processing and emotional regulation. During your consultation, we’ll discuss which administration method may be most suitable for your specific situation and treatment goals.
Ketamine therapy for PTSD represents an off-label application, meaning it’s not FDA-approved specifically for post-traumatic stress disorder. However, growing research demonstrates significant efficacy for PTSD symptoms, particularly when conventional treatments have failed to provide adequate relief.
Ketamine functions as a noncompetitive NMDA receptor antagonist, rapidly modulating glutamate neurotransmission in the brain. Glutamate is the primary excitatory neurotransmitter and plays a critical role in learning, memory formation, and emotional processing—all systems disrupted in PTSD.
Traumatic experiences produce intense glutamate release that can lead to dysregulated fear memory consolidation. In PTSD, memories of the traumatic event become abnormally persistent and intrusive, triggering intense emotional and physiological responses. Research shows that people with PTSD have altered glutamate activity in brain regions involved in fear processing, including the amygdala, hippocampus, and prefrontal cortex.
By blocking NMDA receptors, ketamine rapidly increases glutamate signaling through alternative pathways and promotes neuroplasticity—the brain’s ability to form new neural connections. This may help disrupt overly strong fear memories and facilitate the formation of new, more adaptive memory associations. Ketamine’s neuroplastic effects may also help restore normal function in brain circuits responsible for emotional regulation and threat assessment.
The rapid onset of ketamine’s effects distinguishes it from conventional PTSD medications. While traditional SSRIs and SNRIs require 8-12 weeks of daily use to achieve maximum benefit, ketamine research shows symptom improvement can occur within 24 hours following administration. This quick action may be particularly valuable for individuals with severe PTSD symptoms causing significant functional impairment or safety concerns.
Emerging research also suggests ketamine may be particularly effective when combined with trauma-focused psychotherapy. The neuroplastic effects of ketamine might enhance the brain’s ability to process traumatic memories and form new associations during therapeutic work, potentially improving outcomes from evidence-based psychotherapy approaches like prolonged exposure or cognitive processing therapy.
Your PTSD treatment journey at Ketavita begins with a thorough evaluation. We’ll discuss your trauma history in a sensitive, supportive manner including when the traumatic event(s) occurred, current PTSD symptoms you experience across all four symptom clusters, severity and frequency of intrusive memories, nightmares, or flashbacks, avoidance behaviors and their impact on your life, and co-occurring conditions like depression or anxiety.
We’ll also review your treatment history in detail: all medications tried with their doses and duration, your experience with trauma-focused psychotherapy including what approaches you’ve tried, response to each treatment attempt, any side effects experienced, and current medications you’re taking. This comprehensive assessment helps us determine if ketamine therapy is appropriate for your PTSD and develop the most effective treatment approach.
For IV ketamine therapy, treatment typically involves a series of infusions over several weeks. During each session, you’ll receive your ketamine infusion while resting in a private, comfortable treatment room. We monitor your vital signs continuously throughout the 40-minute infusion. You may experience mild dissociative effects during treatment—feelings of detachment or altered perception—but these are temporary and resolve within 1-2 hours.
For IM ketamine therapy, ketamine is administered as a simple intramuscular injection. The medication is absorbed through muscle tissue into the bloodstream. Administration takes only minutes, though you’ll still spend time in our office for observation after injection. Effects and monitoring procedures are similar to IV therapy.
After each treatment session, you’ll spend additional time in our office for recovery and monitoring before leaving. You cannot drive for 24 hours after ketamine treatment and must bring someone to drive you home. Most patients tolerate ketamine well, with common side effects including temporary dissociation, mild nausea, slight blood pressure elevation during infusion, and temporary dizziness.
Response to ketamine therapy for PTSD varies among individuals. Research shows many patients experience significant symptom reduction within 24 hours to one week following ketamine treatment. The duration of benefit also varies—some patients maintain improvement for several weeks after a single infusion, while others benefit from a series of treatments followed by maintenance sessions. We use standardized PTSD assessment tools to track your progress across all symptom clusters and adjust treatment based on your response.
Ketamine therapy for PTSD may be appropriate if you’ve struggled with persistent symptoms despite conventional treatment attempts. You may be a candidate if you’ve tried at least one SSRI or SNRI medication at maximum tolerated dose for adequate duration without sufficient relief, completed or attempted trauma-focused psychotherapy like prolonged exposure or CPT without adequate benefit, found that combination treatment of medication plus therapy hasn’t provided satisfactory symptom control, or continue to have intrusive memories, avoidance behaviors, or hyperarousal symptoms that significantly impair your functioning despite treatment.
Good candidates for ketamine therapy are adults with diagnosed PTSD who remain significantly symptomatic despite appropriate trials of first-line treatments. Research suggests ketamine may be effective across various types of trauma exposure, including combat-related trauma, interpersonal violence, accidents, and other traumatic events.
Certain factors may affect treatment suitability. During evaluation, we review cardiovascular health (ketamine temporarily raises blood pressure), history of psychosis or dissociative disorders, substance use history particularly involving dissociative drugs, and any medications that might interact with ketamine. Your complete medical and psychiatric history helps ensure safe, appropriate treatment.
It’s important to understand that ketamine therapy for PTSD represents an off-label use, though the evidence base is growing substantially. Multiple systematic reviews and meta-analyses now demonstrate significant PTSD symptom reduction with ketamine treatment. We discuss current research findings transparently during consultation so you can make fully informed treatment decisions.
Our ketamine protocols for PTSD are informed by substantial research demonstrating rapid symptom reduction. Systematic reviews and meta-analyses show that ketamine significantly reduces PTSD symptom scores on standardized measures like the Clinician-Administered PTSD Scale and PTSD Checklist, with benefits emerging as early as 24 hours after treatment and persisting for weeks.
Safety is paramount in all our treatments. Ketamine has been used safely in medical settings for decades, and we follow established safety protocols for subanesthetic dosing in psychiatric applications. All treatments are administered by licensed medical professionals with appropriate training, monitoring equipment, and emergency protocols.
We recognize that effective PTSD management typically requires comprehensive treatment. While ketamine can provide rapid symptom relief, we strongly encourage continued engagement with trauma-focused psychotherapy, appropriate medication management when indicated, and other evidence-based PTSD interventions. Ketamine may be particularly effective when combined with therapy, as the neuroplastic effects might facilitate trauma processing and therapeutic learning.
Research specifically examining ketamine combined with trauma-focused psychotherapy shows promising results. The enhanced neuroplasticity induced by ketamine may help patients engage more effectively in exposure-based treatments and process traumatic memories more adaptively. We work collaboratively with your therapist when you’re receiving concurrent psychotherapy.
Patient education is essential to our approach. We ensure you understand how ketamine works differently from conventional PTSD medications, what the research shows about efficacy and timing of effects, realistic expectations for symptom improvement, potential side effects or risks, and how ketamine fits into comprehensive PTSD treatment. Informed patients are better positioned to achieve optimal outcomes.
Ketamine therapy for PTSD is typically not covered by insurance as it represents off-label use. We provide transparent pricing information during your consultation so you can make informed decisions about treatment.
IV ketamine therapy for PTSD is $395 per session. A typical initial treatment series involves 6-8 infusions over 2-4 weeks, with maintenance sessions scheduled as needed based on symptom recurrence. The total investment depends on how many sessions you require and whether ongoing maintenance is necessary to maintain benefits. Research suggests benefits can last several weeks following a series of infusions, though individual response varies.
We understand that cost is an important consideration, especially after already trying multiple treatments without success. However, many patients with treatment-resistant PTSD find that even significant symptom reduction—decreased intrusive memories, improved sleep, reduced hypervigilance—substantially improves their quality of life and functioning, justifying the investment in their recovery.
While insurance typically doesn’t cover ketamine therapy for PTSD, we can provide receipts and clinical documentation that you may submit to your insurance company for possible out-of-network reimbursement. Coverage decisions are made by individual insurance companies based on their policies.
If you’ve been struggling with post-traumatic stress disorder despite trying conventional treatments, ketamine therapy at Ketavita Wellness Clinic may offer new hope. Our evidence-based approach provides rapid symptom relief through glutamate modulation that works differently than standard PTSD medications.
Schedule a consultation to discuss your trauma history and current symptoms, explore whether ketamine therapy is appropriate for your situation, and develop a personalized treatment plan designed to help you reclaim your life from the persistent effects of trauma.
Living with treatment-resistant PTSD is exhausting and isolating, but you don’t have to accept inadequate symptom control. Contact us today to learn how ketamine therapy can help you achieve the relief and recovery you’ve been seeking.
Research demonstrates significant PTSD symptom reduction with ketamine treatment. Systematic reviews and meta-analyses show improvements in PTSD symptom scores, with many patients experiencing meaningful symptom reduction within 24 hours to one week after treatment. Studies report prolonged time to symptom relapse compared to placebo, suggesting sustained benefits.
Many patients experience rapid symptom improvement. Research shows significant reductions in PTSD symptoms can occur within 24 hours after ketamine administration, with benefits continuing through the first week. This rapid onset distinguishes ketamine from conventional PTSD medications that require 8-12 weeks to reach full effect.
Duration of benefit varies among individuals. Research indicates symptom improvements can persist for several weeks following a series of ketamine infusions. Some patients maintain benefits for extended periods, while others benefit from maintenance sessions to sustain symptom control. We monitor your response and recommend maintenance schedules based on your individual pattern.
Yes, in most cases. Many patients receive ketamine therapy while continuing their existing medication regimen. We’ll review all your current medications during consultation to ensure there are no contraindications. Never discontinue medications without consulting your prescribing physician.
Yes, we strongly encourage continued engagement with trauma-focused psychotherapy. Emerging research suggests ketamine combined with therapies like prolonged exposure or cognitive processing therapy may be more effective than ketamine alone. The neuroplastic effects of ketamine might enhance your ability to process traumatic memories during therapy sessions.
No. Ketamine is not a cure for PTSD. It’s a treatment that can provide significant symptom relief, potentially allowing you to engage more effectively in trauma-focused therapy and other recovery activities. PTSD is a chronic condition typically requiring ongoing management, though many people achieve substantial recovery with appropriate treatment.
Research includes PTSD patients with various trauma exposures including combat trauma, interpersonal violence, accidents, and other traumatic events. Current evidence suggests ketamine may be effective across different trauma types, though more research is needed to identify which presentations respond best.
The most common side effects are temporary and occur during or shortly after treatment: dissociative feelings, mild nausea, temporary blood pressure elevation, and dizziness. These effects typically resolve within 1-2 hours. Serious side effects are rare when ketamine is administered properly in medical settings by trained professionals.
When used as prescribed in medical settings under professional supervision, ketamine does not typically cause addiction. We carefully screen patients, monitor for signs of misuse, and follow established protocols to ensure safe, appropriate use. Patients with active substance use disorders may not be appropriate candidates.
Mental Health Conditions
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481